ANTI-GAD AND C-PEPTIDE IN EARLY-ONSET NON-OVERWEIGHT PATIENTS WITH TYPE 2 DIABETES: IMPLICATIONS FOR LADA SCREENING. YHCĐ. 2026;67(CĐ11-NCKH). doi:10.52163/yhc.v67iCD11.6038